 | • レポートコード：QYR9NV18128 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、マントル細胞リンパ腫治療法の世界市場について調査・分析し、マントル細胞リンパ腫治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（病院、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のマントル細胞リンパ腫治療法市場動向 ・主要企業別マーケットシェア ・マントル細胞リンパ腫治療法の種類別市場規模2014-2019 （併用療法、単剤療法） ・マントル細胞リンパ腫治療法の用途別市場規模2014-2019 （病院、研究所、その他） ・マントル細胞リンパ腫治療法の北米市場：主要企業・種類別/用途別市場規模 ・マントル細胞リンパ腫治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・マントル細胞リンパ腫治療法の中国市場：主要企業・種類別/用途別市場規模 ・マントル細胞リンパ腫治療法の日本国内市場：主要企業・種類別/用途別市場規模 ・マントル細胞リンパ腫治療法の東南アジア市場：主要企業・種類別/用途別市場規模 ・マントル細胞リンパ腫治療法のインド市場：主要企業・種類別/用途別市場規模 ・マントル細胞リンパ腫治療法の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Allergan Plc、AstraZeneca Plc、Celgene Corp.、Johnson & Johnson Services Inc.、Takeda Pharmaceutical Co. Ltd.） ・マントル細胞リンパ腫治療法の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal antibody (mAb) has led to substantial achievement in immunotherapeutic strategies for B-cell lymphomas including MCL.Nonetheless, progress in the clinical use of mAbs is hindered by poor efficacy, off-target toxicities and drug resistance. Thus, novel mAbs engineering and approaches to improve target specificity and enhance affinity and potency are required.
In 2018, the global Mantle Cell Lymphoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Mantle Cell Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mantle Cell Lymphoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Allergan Plc
AstraZeneca Plc
Celgene Corp.
Johnson & Johnson Services Inc.
Takeda Pharmaceutical Co. Ltd.
…
Market segment by Type, the product can be split into
Combination Therapy
Monotherapy
Market segment by Application, split into
Hospital
Research Institute
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Mantle Cell Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Mantle Cell Lymphoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Mantle Cell Lymphoma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Mantle Cell Lymphoma Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Combination Therapy
1.4.3 Monotherapy
1.5 Market by Application
1.5.1 Global Mantle Cell Lymphoma Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Research Institute
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Mantle Cell Lymphoma Therapeutics Market Size
2.2 Mantle Cell Lymphoma Therapeutics Growth Trends by Regions
2.2.1 Mantle Cell Lymphoma Therapeutics Market Size by Regions (2019-2025)
2.2.2 Mantle Cell Lymphoma Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Mantle Cell Lymphoma Therapeutics Market Size by by Players
3.1.1 Global Mantle Cell Lymphoma Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Mantle Cell Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Mantle Cell Lymphoma Therapeutics Key Players Head office and Area Served
3.3 Key Players Mantle Cell Lymphoma Therapeutics Product/Solution/Service
3.4 Date of Enter into Mantle Cell Lymphoma Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Mantle Cell Lymphoma Therapeutics Market Size by Type (2014-2019)
4.2 Global Mantle Cell Lymphoma Therapeutics Market Size by Application (2014-2019)
5 North America
5.1 North America Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
5.2 Mantle Cell Lymphoma Therapeutics Key Players in North America
5.3 North America Mantle Cell Lymphoma Therapeutics Market Size by Type
5.4 North America Mantle Cell Lymphoma Therapeutics Market Size by Application
6 Europe
6.1 Europe Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
6.2 Mantle Cell Lymphoma Therapeutics Key Players in Europe
6.3 Europe Mantle Cell Lymphoma Therapeutics Market Size by Type
6.4 Europe Mantle Cell Lymphoma Therapeutics Market Size by Application
7 China
7.1 China Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
7.2 Mantle Cell Lymphoma Therapeutics Key Players in China
7.3 China Mantle Cell Lymphoma Therapeutics Market Size by Type
7.4 China Mantle Cell Lymphoma Therapeutics Market Size by Application
8 Japan
8.1 Japan Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
8.2 Mantle Cell Lymphoma Therapeutics Key Players in Japan
8.3 Japan Mantle Cell Lymphoma Therapeutics Market Size by Type
8.4 Japan Mantle Cell Lymphoma Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
9.2 Mantle Cell Lymphoma Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size by Type
9.4 Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size by Application
10 India
10.1 India Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
10.2 Mantle Cell Lymphoma Therapeutics Key Players in India
10.3 India Mantle Cell Lymphoma Therapeutics Market Size by Type
10.4 India Mantle Cell Lymphoma Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
11.2 Mantle Cell Lymphoma Therapeutics Key Players in Central & South America
11.3 Central & South America Mantle Cell Lymphoma Therapeutics Market Size by Type
11.4 Central & South America Mantle Cell Lymphoma Therapeutics Market Size by Application
12 International Players Profiles
12.1 Allergan Plc
12.1.1 Allergan Plc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Mantle Cell Lymphoma Therapeutics Introduction
12.1.4 Allergan Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2014-2019))
12.1.5 Allergan Plc Recent Development
12.2 AstraZeneca Plc
12.2.1 AstraZeneca Plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Mantle Cell Lymphoma Therapeutics Introduction
12.2.4 AstraZeneca Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
12.2.5 AstraZeneca Plc Recent Development
12.3 Celgene Corp.
12.3.1 Celgene Corp. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Mantle Cell Lymphoma Therapeutics Introduction
12.3.4 Celgene Corp. Revenue in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
12.3.5 Celgene Corp. Recent Development
12.4 Johnson & Johnson Services Inc.
12.4.1 Johnson & Johnson Services Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Mantle Cell Lymphoma Therapeutics Introduction
12.4.4 Johnson & Johnson Services Inc. Revenue in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
12.4.5 Johnson & Johnson Services Inc. Recent Development
12.5 Takeda Pharmaceutical Co. Ltd.
12.5.1 Takeda Pharmaceutical Co. Ltd. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Mantle Cell Lymphoma Therapeutics Introduction
12.5.4 Takeda Pharmaceutical Co. Ltd. Revenue in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
12.5.5 Takeda Pharmaceutical Co. Ltd. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Mantle Cell Lymphoma Therapeutics Key Market Segments
Table Key Players Mantle Cell Lymphoma Therapeutics Covered
Table Global Mantle Cell Lymphoma Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Combination Therapy Figures
Table Key Players of Combination Therapy
Figuer Monotherapy Figures
Table Key Players of Monotherapy
Table Global Mantle Cell Lymphoma Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Mantle Cell Lymphoma Therapeutics Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Research Institute Case Studies
Figure Other Case Studies
Figure Mantle Cell Lymphoma Therapeutics Report Years Considered
Figure Global Mantle Cell Lymphoma Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Mantle Cell Lymphoma Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Mantle Cell Lymphoma Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Mantle Cell Lymphoma Therapeutics Market Share by Regions 2014-2019
Figure Global Mantle Cell Lymphoma Therapeutics Market Share by Regions 2014-2019
Figure Global Mantle Cell Lymphoma Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Mantle Cell Lymphoma Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Mantle Cell Lymphoma Therapeutics Market Share by by Players (2014-2019)
Figure Global Mantle Cell Lymphoma Therapeutics Market Share by by Players in 2018
Table Global Mantle Cell Lymphoma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Mantle Cell Lymphoma Therapeutics Product/Solution/Service
Table Date of Enter into Mantle Cell Lymphoma Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Mantle Cell Lymphoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Mantle Cell Lymphoma Therapeutics Market Size Share by Type (2014-2019)
Figure Global Mantle Cell Lymphoma Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Mantle Cell Lymphoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Mantle Cell Lymphoma Therapeutics Market Size Share by Application (2014-2019)
Figure Global Mantle Cell Lymphoma Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by Application in 2018
Figure North America Mantle Cell Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Mantle Cell Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Mantle Cell Lymphoma Therapeutics Market Share (2018-2019)
Table North America Mantle Cell Lymphoma Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Mantle Cell Lymphoma Therapeutics Market Share by Type 2014-2019
Table North America Mantle Cell Lymphoma Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Mantle Cell Lymphoma Therapeutics Market Share by Application 2014-2019
Figure Europe Mantle Cell Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Mantle Cell Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Mantle Cell Lymphoma Therapeutics Market Share (2018-2019)
Table Europe Mantle Cell Lymphoma Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Mantle Cell Lymphoma Therapeutics Market Share by Type 2014-2019
Table Europe Mantle Cell Lymphoma Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Mantle Cell Lymphoma Therapeutics Market Share by Application 2014-2019
Figure China Mantle Cell Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Mantle Cell Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Mantle Cell Lymphoma Therapeutics Market Share (2018-2019)
Table China Mantle Cell Lymphoma Therapeutics Market Size by Type 2014-2019 (Million US$)
Table China Mantle Cell Lymphoma Therapeutics Market Share by Type 2014-2019
Table China Mantle Cell Lymphoma Therapeutics Market Size by Application 2014-2019 (Million US$)
Table China Mantle Cell Lymphoma Therapeutics Market Share by Application 2014-2019
Figure Japan Mantle Cell Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Mantle Cell Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Mantle Cell Lymphoma Therapeutics Market Share (2018-2019)
Table Japan Mantle Cell Lymphoma Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Japan Mantle Cell Lymphoma Therapeutics Market Share by Type 2014-2019
Table Japan Mantle Cell Lymphoma Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Japan Mantle Cell Lymphoma Therapeutics Market Share by Application 2014-2019
Figure Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Mantle Cell Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Mantle Cell Lymphoma Therapeutics Market Share (2018-2019)
Table Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Mantle Cell Lymphoma Therapeutics Market Share by Type 2014-2019
Table Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Mantle Cell Lymphoma Therapeutics Market Share by Application 2014-2019
Figure India Mantle Cell Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Mantle Cell Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Mantle Cell Lymphoma Therapeutics Market Share (2018-2019)
Table India Mantle Cell Lymphoma Therapeutics Market Size by Type 2014-2019 (Million US$)
Table India Mantle Cell Lymphoma Therapeutics Market Share by Type 2014-2019
Table India Mantle Cell Lymphoma Therapeutics Market Size by Application 2014-2019 (Million US$)
Table India Mantle Cell Lymphoma Therapeutics Market Share by Application 2014-2019
Figure Central & South America Mantle Cell Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Mantle Cell Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Mantle Cell Lymphoma Therapeutics Market Share (2018-2019)
Table Central & South America Mantle Cell Lymphoma Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Mantle Cell Lymphoma Therapeutics Market Share by Type 2014-2019
Table Central & South America Mantle Cell Lymphoma Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Mantle Cell Lymphoma Therapeutics Market Share by Application 2014-2019
Table Allergan Plc Company Details
Table Allergan Plc Revenue in Mantle Cell Lymphoma Therapeutics Business 2014-2019 (Million US$)
Figure Allergan Plc Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
Table Allergan Plc Recent Development
Table AstraZeneca Plc Company Details
Table AstraZeneca Plc Revenue in Mantle Cell Lymphoma Therapeutics Business 2014-2019 (Million US$)
Figure AstraZeneca Plc Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
Table AstraZeneca Plc Recent Development
Table Celgene Corp. Company Details
Table Celgene Corp. Revenue in Mantle Cell Lymphoma Therapeutics Business 2014-2019 (Million US$)
Figure Celgene Corp. Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
Table Celgene Corp. Recent Development
Table Johnson & Johnson Services Inc. Company Details
Table Johnson & Johnson Services Inc. Revenue in Mantle Cell Lymphoma Therapeutics Business 2014-2019 (Million US$)
Figure Johnson & Johnson Services Inc. Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
Table Johnson & Johnson Services Inc. Recent Development
Table Takeda Pharmaceutical Co. Ltd. Company Details
Table Takeda Pharmaceutical Co. Ltd. Revenue in Mantle Cell Lymphoma Therapeutics Business 2014-2019 (Million US$)
Figure Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
Table Takeda Pharmaceutical Co. Ltd. Recent Development
Table Global Mantle Cell Lymphoma Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Mantle Cell Lymphoma Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Mantle Cell Lymphoma Therapeutics Market Size Share by Regions in 2025
Figure North America Mantle Cell Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Mantle Cell Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Mantle Cell Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Mantle Cell Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Mantle Cell Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Mantle Cell Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Mantle Cell Lymphoma Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Mantle Cell Lymphoma Therapeutics Market Size by Product (2019-2025)
Figure Global Mantle Cell Lymphoma Therapeutics Market Size by Product in 2025
Table Global Mantle Cell Lymphoma Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Mantle Cell Lymphoma Therapeutics Market Size by Application (2019-2025)
Figure Global Mantle Cell Lymphoma Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
マントル細胞リンパ腫治療法のグローバル市場：規模・現状・予測2019-2025 Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal antibody (mAb) has led to substantial achievement in immunotherapeutic strategies for B-cell lymphomas including MCL.Nonetheless, progress in the clinical…- マントル細胞リンパ腫治療法のグローバル市場：規模・現状・予測2019-2025 Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal antibody (mAb) has led to substantial achievement in immunotherapeutic strategies for B-cell lymphomas including MCL.Nonetheless, progress in the clinical…
- BCL-2（B細胞リンパ腫2）阻害剤のグローバル市場：規模・現状・予測2019-2025 Symptoms of hematologic malignancies are usually mild or inconspicuous, leading to delays in diagnosis and treatment of indications.BCL-2 (B-cell lymphoma 2) inhibitors regulates the correlation of cell apoptosis at the mitochondrial level, which has the potential to be a therapeutic target for hem…
- BCL-2（B細胞リンパ腫2）阻害剤のグローバル市場：規模・現状・予測2019-2025 Symptoms of hematologic malignancies are usually mild or inconspicuous, leading to delays in diagnosis and treatment of indications.BCL-2 (B-cell lymphoma 2) inhibitors regulates the correlation of cell apoptosis at the mitochondrial level, which has the potential to be a therapeutic target for hem…
- B細胞リンパ腫2阻害剤のグローバル市場：規模・現状・予測2019-2025 Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.The symptoms of hematological malignancies are often mild …